Search Results - "Sanford, Tom"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3

    A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo by Rennert, Paul, Su, Lihe, Dufort, Fay, Birt, Alyssa, Sanford, Tom, Wu, Lan, Ambrose, Christine, Lobb, Roy

    Published in Blood (13-11-2019)
    “…Introduction CAR T cells that recognize the antigen CD19 (CAR19s) have achieved remarkable success in otherwise untreatable B cell malignancies including…”
    Get full text
    Journal Article
  4. 4

    Anti-CD19 CAR T Cells That Secrete a Biparatopic Anti-CLEC12A Bridging Protein Have Potent Activity Against Highly Aggressive Acute Myeloid Leukemia In Vitro and In Vivo by Rennert, Paul D, Dufort, Fay J, Su, Lihe, Sanford, Tom, Birt, Alyssa, Wu, Lan, Lobb, Roy R, Ambrose, Christine

    Published in Molecular cancer therapeutics (01-10-2021)
    “…Refractory acute myeloid leukemia (AML) remains an incurable malignancy despite the clinical use of novel targeted therapies, new antibody-based therapies, and…”
    Get full text
    Journal Article
  5. 5

    Abstract B020: CAR-CD19 T cells secreting multi-antigen bridging proteins eliminate solid tumors by Rennert, Paul, Ambrose, Christine, Su, Lihe, Dufort, Fay, Birt, Alyssa, Sanford, Tom, Wu, Lan, Lobb, Roy

    Published in Molecular cancer therapeutics (01-12-2019)
    “…Introduction: Clinical data from diverse cell therapy trials highlight two critical issues. The first is resistance to, and relapse from, therapy due to…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13